The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro and Zepbound, to treat the "major global health challenge" of obesity.
WHO releases new guidance for GLP-1 weight loss drugs: What to know
WGN Radio 720 News13 hrs ago73
People Top Story
VICE
The Post and Courier
New York Post Health
Verywell Health
St. Louis Public Radio
Star Beacon
Essentiallysports Golf